{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:38:40Z","timestamp":1782938320285,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":469,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.modpat.2022.100043","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:45:54Z","timestamp":1673311554000},"page":"100043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2\/BCL6 Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Come","family":"Sesboue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jeanneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Chauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Laharanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Amintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krimo","family":"Bouabdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.modpat.2022.100043_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00277-018-3501-8","article-title":"Burden of illness of follicular lymphoma and marginal zone lymphoma","volume":"98","author":"Monga","year":"2019","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dreyling","year":"2021","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/PAS.0000000000001399","article-title":"Unusual variants of follicular lymphoma: case-based review","volume":"44","author":"Chapman","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2022.100043_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3324\/haematol.2014.120956","article-title":"Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers","volume":"100","author":"van den Brand","year":"2015","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2022.100043_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/his.12076","article-title":"Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups","volume":"62","author":"Marafioti","year":"2013","journal-title":"Histopathology"},{"issue":"suppl 1","key":"10.1016\/j.modpat.2022.100043_bib8","doi-asserted-by":"crossref","first-page":"A141","DOI":"10.1093\/ajcp\/140.suppl1.141","article-title":"Nodal marginal zone lymphoma with aberrant CD10 expression: a case report","volume":"140","author":"Song","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2022.100043_bib9","first-page":"4649","article-title":"BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH\/BCL2","volume":"29","author":"Gollub","year":"2009","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib10","first-page":"3","article-title":"A\u00a0subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma","volume":"9","author":"van den Brand","year":"2016","journal-title":"J\u00a0Hematop"},{"key":"10.1016\/j.modpat.2022.100043_bib11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A\u00a0distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2022.100043_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2022.100043_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.modpat.2022.100043_bib15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/bjh.17395","article-title":"Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network","volume":"193","author":"Bommier","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib16","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/HS9.0000000000000169","article-title":"The need for a consensus next-generation sequencing panel for mature lymphoid malignancies","volume":"3","author":"Sujobert","year":"2018","journal-title":"Hemasphere"},{"issue":"11","key":"10.1016\/j.modpat.2022.100043_bib17","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.modpat.2022.100043_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.modpat.2022.100043_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: a translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib20","first-page":"7","article-title":"Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (review)","volume":"56","author":"Zhu","year":"2020","journal-title":"Int J Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2022.100043_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jmoldx.2017.07.007","article-title":"Determination of molecular subtypes of diffuse large B-cell lymphoma using a reverse transcriptase multiplex ligation-dependent probe amplification classifier: a CALYM study","volume":"19","author":"Bob\u00e9e","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.modpat.2022.100043_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.modpat.2022.100043_bib23","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/1078-0432.CCR-16-1922","article-title":"Biological and clinical relevance of associated genomic alterations in MYD88 L265P and non-L265P-mutated diffuse large B-cell lymphoma: analysis of 361 cases","volume":"23","author":"Dubois","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/annonc\/mdx413","article-title":"ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma","volume":"29","author":"Buske","year":"2018","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2022.100043_bib25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","article-title":"Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components","volume":"34","author":"Younes","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2022.100043_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.5858\/arpa.2018-0217-RA","article-title":"Follicular lymphoma diagnostic caveats and updates","volume":"142","author":"Choi","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2559.2007.02951.x","article-title":"Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases","volume":"52","author":"Naresh","year":"2008","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2022.100043_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2009.146","article-title":"Follicular lymphomas with plasmacytic differentiation include two subtypes","volume":"23","author":"Gradowski","year":"2010","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation","volume":"205","author":"Schraders","year":"2005","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/10428194.2020.1855347","article-title":"Expression of germinal center cell markers by extranodal marginal zone lymphomas of MALT type within colonized follicles, a diagnostic pitfall with follicular lymphoma","volume":"62","author":"Poveda","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.modpat.2022.100043_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ajh.21729","article-title":"An unusual nodal marginal zone lymphoma with bright CD10 expression: a potential diagnostic pitfall","volume":"85","author":"Wang","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2022.100043_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.modpat.2022.100043_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ajcp\/111.4.488","article-title":"Frequency of CD43 expression in non-Hodgkin lymphoma: a survey of 742 cases and further characterization of rare CD43+ follicular lymphomas","volume":"111","author":"Lai","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","article-title":"IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas","volume":"61","author":"Falini","year":"2012","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.modpat.2022.100043_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13015","article-title":"Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma\u2014diagnostic and therapeutic implications","volume":"70","author":"van den Brand","year":"2017","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.modpat.2022.100043_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.modpat.2022.100043_bib37","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41408-020-0322-5","article-title":"Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma","volume":"10","author":"Bob\u00e9e","year":"2020","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41379-021-00954-z","article-title":"A\u00a0novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform","volume":"35","author":"Zhang","year":"2021","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib40","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2022.100043_bib41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.18.00605","article-title":"First-line treatment of patients with indolent non-Hodgkin lymphoma or mantle-cell lymphoma with bendamustine plus rituximab versus R-CHOP or R-CVP: results of the BRIGHT 5-year follow-up study","volume":"37","author":"Flinn","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.modpat.2022.100043_bib42","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2017.76.8960","article-title":"Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study: influence of chemotherapy on efficacy and safety","volume":"36","author":"Hiddemann","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.modpat.2022.100043_bib43","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.19.01073","article-title":"Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study","volume":"37","author":"Bachy","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9873","key":"10.1016\/j.modpat.2022.100043_bib44","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.modpat.2022.100043_bib45","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2022.100043_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2020008743","article-title":"KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas","volume":"138","author":"Heward","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2022.100043_bib47","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/s41375-020-0908-8","article-title":"CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP\/EP300-mutated lymphomas","volume":"34","author":"Veazey","year":"2020","journal-title":"Leukemia"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:14:05Z","timestamp":1760213645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0893395222000436"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100043","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2\u2212\/BCL6\u2212 Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100043"}}